We found strong evidence that a decrease in plasma ACE levels, the mechanism of action of ACE inhibitors, increased colorectal cancer risk (OR per unit decrease in inverse-rank normalized protein expression: 1.08; 1.03, 1.13; 9.36x10-4) (Figure 2). This evidence concerns the gene ACE and colorectal cancer.